Lanean...

Immunomodulatory Therapy for Melanoma: Ipilimumab and Beyond

In 2011, the FDA approved the first new therapy for melanoma in over a decade, ipilimumab (Yervoy). Ipilimumab is a novel antibody that blockscytotoxic T lymphocyte-associated antigen 4 (CTLA-4), a regulatory molecule expressed on activated T cells. Blockade of this important immune checkpoint can l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Callahan, Margaret K., Postow, Michael A., Wolchok, Jedd D.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3653249/
https://ncbi.nlm.nih.gov/pubmed/23438382
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.clindermatol.2012.08.006
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!